GW2974
CAS 202272-68-2 MFCD04974495
化学结构图
SMILES: CN(C)C1C=C2C(NC3C=C4C=NN(CC5C=CC=CC=5)C4=CC=3)=NC=NC2=CN=1
化学属性
| Mol. Formula | C23H21N7 |
|---|---|
| Mol. Weight | 395.46 |
别名和识别编码
| Chemical Name | GW2974 |
|---|---|
| Synonym | N4-(1-Benzyl-1H-indazol-5-yl)-N6,N6-dimethyl-pyrido[3,4-d]pyrimidine-4,6-diamine |
| MDL Number | MFCD04974495 |
| PubChem Substance ID | 24278451 |
| CAS Number | 202272-68-2 |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- Approved Therapeutics/Drug Candidates, Bioactive Small Molecules, Cancer Research, Cell Biology, Cell Signaling and Neuroscience, EGFR Tyrosine Kinase Inhibitors, Epidermal Growth Factor Receptor & ErbII (EGFR/ErbB-2), G, GlaxoSmithKline, Kinase/Phosphatase Biology, Protein Kinase Inhibitors, Receptor Tyrosine Kinase Biology, Receptor Tyrosine Kinase Inhibitors, Tumor Growth Regulation
- {SA} Approved Therapeutics/Drug Candidates, Bioactive Small Molecules, Cancer Research, Cell Biology, Cell Signaling and Neuroscience, EGFR Tyrosine Kinase Inhibitors, Epidermal Growth Factor Receptor & ErbII (EGFR/ErbB-2), G, GlaxoSmithKli
- {SNA} Approved Therapeutics/Drug C
相关文献及参考
- Rusnack, D. W., et al., The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: potential therapy for cancer. CRC Handbook of Microbiology 61 , 7196, (2001)
